Invention Grant
- Patent Title: Pharmaceutically acceptable salts of psilocin and uses thereof
-
Application No.: US17520275Application Date: 2021-11-05
-
Publication No.: US11312684B1Publication Date: 2022-04-26
- Inventor: David E. Nichols , Graham Johnson , Hooshang S. Zavareh , Claire Wombwell , Daniel Rixson , Peter Haddow , Carrie Sheard , Alexander Schwarz
- Applicant: Eleusis Therapeutics US, Inc.
- Applicant Address: US NY New York
- Assignee: Eleusis Therapeutics US, Inc.
- Current Assignee: Eleusis Therapeutics US, Inc.
- Current Assignee Address: US NY New York
- Agency: Clark & Elbing LLP
- Main IPC: C07D209/16
- IPC: C07D209/16 ; A61K31/4045 ; C07C63/08
Abstract:
The present invention composition features pharmaceutically acceptable salts of psilocin and compositions thereof. The pharmaceutically acceptable salts of psilocin may be used to treat a disease or condition, such as a neurological injury, an inflammatory condition, chronic pain, or a psychological condition, in a subject in need thereof.
Information query
